Thymosin Alpha-1 (Tα1) is a synthetic peptide fragment derived from prothymosin alpha. It is best known for its powerful immunomodulatory properties, particularly in enhancing T-cell function and supporting innate immune responses. Tα1 has been used in numerous studies on immune restoration, chronic infections, cancer, and viral defense.
Its mechanism involves upregulating toll-like receptors and modulating cytokine activity, making it a focus in clinical immunotherapy and anti-inflammatory research. Thymosin Alpha-1 is often studied in combination with vaccines, antiviral agents, and in immune-compromised models.
Key Characteristics
| Feature | Description |
|---|---|
| Compound | Thymosin Alpha-1 (Tα1) |
| Form | Lyophilized Peptide |
| Strength | Typically 1mg or 2mg per vial |
| Primary Use | Immune modulation, T-cell enhancement, antiviral research |
| Benefit | Stimulates immune response and enhances infection resistance |
Benefits
- Enhances T-cell and NK-cell activity
- Supports immune system regulation in chronic or suppressed states
- May improve outcomes in antiviral and anti-tumor research
- Synergistic effects with vaccines and immunotherapy agents
- Promising in autoimmune modulation studies
Reviews
There are no reviews yet.